effect of alpha blockers in benign prostatic hyperplasia
Not Applicable
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2021/04/033122
- Lead Sponsor
- DR I C VIGNESH RAJA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Benign prostatic hyperplasia with international prostatic symptom score above 7
Patient on silodosin
Patient on tamsulosin
willing to give informed consent
Exclusion Criteria
Prostate carcinoma
Patients with concomitant HIV, HBV or HCV
Renal failure
Liver disease
Patient planned for cataract surgery.
Psychiatry patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method